English French German Italian Spanish

Grants Awarded

NBIA Disorders Association has funded 25 research grants since 2002, totaling $940,480. Grants are awarded to qualified researchers to initiate pilot studies, the results of which are intended to be used to obtain larger multi-year grant funding. Many of these grants have led to the discovery of NBIA genes and the development of mouse and fruit fly disease models.

In depth information on our December, 2014 research grant awarded and the 3 research grants awarded in April, 2014, can be found under our NEWS link.

We are now accepting applications from interested researchers for research for all NBIA disorders. Please see the grant application on this page for further details. Application deadline is April 1, 2015.

List of Grants Awarded:

  • December 2014: Susan Hayflick, M.D., Oregon Health & Science University, Portland, Oregon, USA. " Examining the role of ischemia in the neurodegenerative disease PKAN. " $45,000.
  • April 2014: Manju Kurian, M.D., University College London, London, England. "Novel Therapeutic Strategies in NBIA: A Gene Therapy Approach for PLA2G6-Associated Neurodegeneration (PLAN)." $150,000.
  • April 2014: Manju Kurian, M.D., University College London, London, England. "Functional Characterization of Newly Identified NBIA Disorders Using Neuronal Cell Models." $44,680.
  • April 2014: Ana Messias, Ph.D., Helmholtz Center, Munich, Germany. "Three-dimensional structure determination and preliminary function analysis of C19orf12, a protein involved in NBIA." $45,000.
  • April 2012:  Tobias Haack, Ph.D., Helmholtz Center, Munich, Germany. “Next generation sequencing for disease gene identification and genetic testing in NBIA.” $40,000.
  • April 2012:  Ulrich Salzer, Ph.D., Medical University of Vienna, Vienna, Austria. “Type and frequency of acanthocytosis in PKAN patients and family members from the region of Cabral and possible links to neurodegeneration.” $25,000.
  • February 2012:  Roberta Leonardi, Ph.D., Dept of Infectious Diseases, St. Jude Children’s Hospital, Memphis, Tenn.  “An adeno-associated virus mediated mouse model for PKAN disease.” $30,000.
  • December 2011:  Arcangela Iuso, Ph.D., Institute of Human Genetics, Helmholtz Center, Munich, Germany.  “Development of cellular and drosophila models to characterize a newly identified NBIA gene.” $30,800.
  • December 2011:  Ody C.M. Sibon, Ph.D., University Medical Center, Groningen, Netherlands. “Investigating the potential of specific pantethine derivatives to treat PKAN.” $40,000.
  • December 2011:  Paul Kotzbauer, M.D., Ph.D., Washington University, St. Louis MO.  “Therapeutic approaches to increase Acyl Coenzyme A production in Neurodegeneration with Brain Iron Accumulation.” $40,000.
  • February 2010:  Lars Timmerman, M.D., Ph.D. & Amande Pauls, M.D., Ph.D., University of Cologne, Cologne Germany. “Stimulation of the Globus pallidus internus in patients with NBIA: prospective analysis of international therapeutic outcomes and development of a therapeutic algorithm.” $30,000.
  • November 2009:  Michael Kruer, M.D., Oregon Health & Science University, Portland OR. “SNP microarray-based disease gene discovery in idiopathic NBIA.” $30,000.
  • November 2008:  Ody C.M. Sibon, Ph.D., University Medical Center, Groningen, Netherlands. “Investigating the potential of pantethine to rescue pantothenate kinase deficiency.” $30,000.
  • November 2008:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Proteomic Analysis of Neuroaxonal Spheroids.” $30,000.
  • December 2007:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Towards clinical therapeutics in PKAN.” $30,000.
  • December 2007:  Paul Kotzbauer, M.D., Ph.D., Washington University, St. Louis MO.   “Combined disruption of mouse PANK2 and PLA2G6 genes to generate an improved animal model of NBIA.” $30,000.
  • December 2007:  Soma Das, Ph.D., University of Chicago, Chicago IL. “Deletion and duplication analysis of the PANK2 and PLA2G6 genes in patients with NBIA.” $30,000.
  • December 2006:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “The molecular pathogenesis of NBIA.” $30,000.
  • December 2005:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Dynamics in brain iron distribution in PKAN.” $30,000.
  • October 2004:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “New gene discovery in NBIA.” $30,000.
  • September 2003:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Toward rational therapies for PKAN.” $30,000.
  • September 2003:  Natalie Canham, M.B., University of Birmingham, Birmingham U.K. “Identification of the gene responsible for autosomal recessive NBIA and Congenital Cerebellar Hypoplasia.”       $30,000.
  • September 2002:  Penelope Hogarth, M.D., Oregon Health & Science University, Portland OR. “Clinical outcome measures in Hallevorden-Spatz Syndrome.”  $30,000.
  • September 2002:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “The biochemical basis for Hallevorden-Spatz Syndrome.” $30,000.
  • September 2002:  Han-Xiang Deng, M.D., Ph.D., Northwestern University Medical School, Chicago, IL. “Development of a mouse model of Hallevorden-Spatz Syndrome.”  $30,000.

 

 

Text Size

Grant Application

Click the link below to download/view the Grant Application.

Download .pdf format

Download .doc format

Connect with Us

Researchers, Clinicians & Other Professionals

Connect with Us

Connect with Us

Donate Now

Sign-up for our Newsletter